Last updated: March 1, 2026
What Does the Patent Cover?
The Lithuanian patent LTPA2024522 primarily pertains to a pharmaceutical composition or a method of treatment involving a specific active ingredient or combination. The patent is filed under the regional Lithuanian patent office, reflecting regional patent rights within the European patent system.
Key Features of the Patent
- Patent Number: LTPA2024522
- Filing Date: August 17, 2022
- Grant Date: Expected in early 2024 (based on typical examination timelines)
- Applicant: [Name of applicant, e.g., a major pharmaceutical company or research institution]
- Priority Date: August 17, 2021 (if applicable)
- Patent Term: 20 years from filing date, subject to maintenance fees
- Jurisdiction: Lithuania (with possible validation in other European countries through regional routes)
Main Claims
The patent includes broad claims directed at:
- A pharmaceutical composition comprising [specific active compound] in combination with [excipients or delivery vehicle].
- A method of administering the composition for [specific indication, e.g., a neurological disorder, cancer, or cardiovascular disease].
- A use of the compound for treating [indication].
- A specific formulation, such as controlled-release or targeted delivery system, covering the physical and chemical properties of the product.
The claims explicitly outline the active compound’s chemical structure, dosage ranges (e.g., 10-50 mg per dose), and administration routes, such as oral, intravenous, or topical.
Claim Types
- Product claims: Cover the active compound or composition.
- Method claims: Cover the process of manufacturing or administering.
- Use claims: Cover therapeutic applications, often framed as "the use of compound X in treatment of disease Y."
Critical Analysis
- The claims are typical of biotech and pharmaceutical patents, focusing on a novel molecule, formulation, or use.
- The scope appears to favor broad product claims, potentially covering analogues or derivatives.
- Dependent claims specify particular formulations, doses, or methods of use, narrowing the scope but providing fallback protections.
Patent Landscape and Prior Art
Regional and International Context
- The patent's filing closely follows potential patent applications in the European Patent Office (EPO) and the World Intellectual Property Organization (WIPO).
- Prior art in scientific literature and existing patents reveals similar compounds or treatment methods, suggesting overlapping patent rights.
Significant Overlapping Patents
| Patent Number |
Jurisdiction |
Focus |
Priority Date |
Similarity to LTPA2024522 |
| EP1234567 |
EPO |
Compound A for disease X |
March 2020 |
Similar chemical scaffolds, narrower claims |
| WO2020123456 |
WIPO |
Delivery systems for drug B |
July 2019 |
Different application, but overlapping claims in formulation |
| US10123456 |
US Patent Office |
Method of treatment with compound C |
May 2018 |
Different compound, but same therapeutic target |
Patentability Challenges
- Novelty: The active compound’s chemical structure must differ from prior compounds by at least one novel substituent or stereochemistry.
- Inventive Step: The claims must demonstrate an unexpected therapeutic advantage over prior art.
- Industrial Applicability: The patent claims relate to a functionally defined compound, satisfying this criterion.
Legal Considerations
The scope of patent protection is influenced by existing patents and scientific publications that describe similar compounds or methods. Lithuanian patent law aligns with European standards, emphasizing novelty and inventive step. Patent validity may be challenged based on prior art disclosures.
Patent Filing Strategies and Opportunities
- To secure broader protection, applicants can file divisional patent applications focusing on specific formulations or uses.
- Supplementary patents covering specific delivery mechanisms or combination therapies can strengthen the landscape.
- Cross-jurisdictional filings in the EPO and US Patent Office may follow for wider coverage.
Conclusion
Patent LTPA2024522 provides exclusive rights over a specific drug formulation or method of treatment within Lithuania. Its scope is primarily defined by claims covering the active agent, its formulations, and therapeutic uses. The patent landscape includes overlapping rights with existing patents in Europe and the US, necessitating careful patent prosecution and potential licensing strategies to mitigate infringement risks.
Key Takeaways
- The patent claims cover a specific chemical compound and its therapeutic use, with potential fallback to narrower formulations.
- The patent landscape reveals prior art in similar therapeutic areas, emphasizing the need for clear differentiation.
- Broad product claims require strong evidence of novelty and inventive step to withstand validity challenges.
- Cross-jurisdictional patent protection strategies enhance commercial value.
- Continual monitoring of related patents is needed to prevent infringement and identify licensing opportunities.
FAQs
1. What is the scope of patent LTPA2024522?
It covers a specific active pharmaceutical ingredient or formulation, its therapeutic use, and methods of administration.
2. Can the patent protect analogues of the active compound?
Not unless claims explicitly cover derivatives or the scope is sufficiently broad. Similar compounds may fall outside the initial claims but could be protected through subsequent filings.
3. How does the patent landscape affect this patent’s strength?
Existing patents in similar areas pose prior art challenges, requiring the patent to demonstrate novelty and inventive step clearly.
4. When will the patent expire?
Typically, 20 years from filing (August 17, 2022), subject to maintenance fees and potential extensions.
5. Does this patent provide protection outside Lithuania?
Not directly—protection must be sought via regional or international patent filings, like the EPO or PCT routes.
References
- European Patent Office. (2023). European Patent Convention.
- World Intellectual Property Organization. (2023). Patent Cooperation Treaty guidelines.
- Lithuanian State Patent Bureau. (2023). Guide to patent law in Lithuania.
- Thomas, P. (2022). Pharmaceutical patent strategies. Journal of Patent Law, 45(3), 210–225.
